Skip to main content
. 2016 Dec 14;46(4):1095–1096e. doi: 10.1093/ije/dyw223

Table 3.

The baseline characteristics of participants in the Jinchang Cohort Study

Variables Male, n (%) Female, n (%) Total, n (%)
Sex 26008 (61.7) 16114 (38.3) 42122 (100)
Age, mean ± SD, (years) 46.8±14.1 45.8±11.8 46.4±13.3
Behavioural risk factors
 Current smokersa 15323 (58.9) 218 (1.4) 15541 (36.9)
 Former smokers 3556 (13.7) 48 (0.3) 3604 (8.6)
 Current drinkersb 7841 (30.2) 342 (2.1) 8183 (19.4)
 Former drinkers 1670 (6.4) 38 (0.2) 1708 (4.1)
Height (cm) 171.7 (6.2) 161.9 (5.9) 167.9 (7.7)
Weight (kg) 71.1 (10.4) 59.4 (8.9) 66.6 (11.3)
Systolic blood pressure (SBP), (mmHg) 126.3 ± 19.1 118.7 ± 20.0 123.4 ± 19.8
Diastolic blood  pressure  (DBP), (mmHg) 80.0 ± 12.6 76.5 ± 12.0 78.7 ± 12.5
BMI
 Normal (< 25) 16411 (63.1) 12646 (78.5) 29057 (69.0)
 Overweight (25-29.9) 8709 (33.5) 3024 (18.8) 11733 (27.9)
 Obesity (≥ 30) 888 (3.4) 444 (2.8) 1332 (3.2)
Occupation
 Management and services 6099 (23.5) 3915 (24.3) 10014 (23.8)
 Chemical/metal  production 6614 (25.5) 8000 (49.6) 14614 (34.7)
 Mining/smelting 13295 (51.1) 4199 (26.1) 17494 (41.5)
Hypertensionc 8504 (32.7) 3658 (22.7) 12162 (28.9)
Type 2 diabetesd 2329 (9.0) 832 (5.2) 3161 (7.5)
Hyperlipidaemiae 14112 (54.3) 5448 (33.8) 19560 (46.4)
Self-reported diseases
 Chronic rhinitis 2698 (10.4) 2019 (12.5) 4717 (11.2)
 Gall stones 2082 (8.0) 2155 (13.4) 4237 (10.1)
 Fatty liver 3203 (12.3) 1060 (6.6) 4263 (10.1)
 Cholecystitis 1981 (7.6) 2080 (12.9) 4061 (9.6)
 Protrusion of  intervertebral disc 1986 (7.6) 1830 (11.4) 3816 (9.1)
 Chronic sore throat 1757 (6.8) 1480 (9.2) 3237 (7.7)
 Uterine fibroids 1498 (11.1)
 Chronic gastritis 1628 (6.3) 1090 (6.8) 2718 (6.5)

SD, standard deviation.

a

Current smokers were defined as those who smoked at least one cigarette per day in the past 6 months.

b

Current drinkers were those who drank hard liquor, beer or wine at least once per week during the past 6 months.

c

Hypertension was defined as systolic blood pressure ≥ 140 mmHg or diastolic ≥ 90 mmHg, or self-reported treatment for hypertension.

d

Type 2 diabetes was recorded if participants were on anti-diabetic medications or if their baseline fasting plasma glucose(FPG) was high (≥ 7.0 mmol/l) at the time of cohort entry.

e

Hyperlipidaemia were defined as: TG ≥ 1.70 mmol/l (150 mg/dl), or HDL-C < 0.9 mmol/l (35 mg/dl) in men and < 1.0 mmol/l (39 mg/dl) in women.